Get startedLog in
    Picture of Strides Pharma Science logo

    STAR — Strides Pharma Science Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Strides Pharma Science, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line5472,754-6,525-2,862-1,169
    Depreciation
    Non-Cash Items3,3351,7103,4934,5756,518
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-3,712-1,713-1,876-3,705-546
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities2,0484,814-2,5784417,009
    Capital Expenditures-1,500-2,975-1,434-949-1,182
    Purchase of Fixed Assets
    Other Investing Cash Flow Items14,562-2,2332473,974-321
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities13,062-5,208-1,1873,025-1,503
    Financing Cash Flow Items-1,718-1,394-1,538-2,242-2,922
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-17,094-1584,213-2,139-6,933
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-1,837-5644491,328-1,425